{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:01Z","timestamp":1788815281737,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment with fluocinolone acetonide, hydroquinone, and tretinoin cream is the gold standard for melasma; however, the effects of this treatment in the Chinese population remain unclear. Due to the differences between Chinese and Caucasian subjects, further clinical trials in Chinese patients with melasma are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin creams in Chinese patients with moderate\u2010to\u2010severe melasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited 53 patients who received a generic formulation (triple combination cream, TCC), brand formulation (TRI\u2010LUMA), or placebo once daily for 8\u2009weeks. In weeks 4 and 8, efficacy was evaluated based on the Melasma Severity Scale and Melasma Area and Severity Index. In addition, safety was assessed based on the incidence and severity of treatment\u2010emergent adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The generic TCC group achieved 52.2% efficacy compared to 57.1% in the TRI\u2010LUMA group. There was no significant difference in the incidence of adverse effects between the TCC and TRI\u2010LUMA groups (69.6% and 90.5%, respectively;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). The incidence of adverse events in the placebo group was 0%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Generic TCC was as effective as TRI\u2010LUMA and had a similar safety profile in this study of Chinese subjects with moderate\u2010to\u2010severe melasma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jocd.70205","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T02:50:37Z","timestamp":1745895037000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI\u2010LUMA for the Treatment of Moderate\u2010To\u2010Severe Melasma in Chinese Patients: A Randomized, Single\u2010Center, Placebo\u2010Controlled Trial"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-4786","authenticated-orcid":false,"given":"Honghua","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6782-146X","authenticated-orcid":false,"given":"Chengyao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"},{"name":"Department of Dermatology Linping Hospital of Integrated Traditional Chinese and Western Medicine  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangke","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunfei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University  Yiwu China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1961.01580080114013"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13844"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523\u20101747.ep12696836"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806\u20104841.20143063"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.3.424"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011\u2010199500102\u201000006"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20227068"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019\u20105154.57602"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S80713"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1351608"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1975.01630130042004"},{"issue":"1","key":"e_1_2_12_13_1","first-page":"1","article-title":"Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion","volume":"21","author":"Sofen B.","year":"2016","journal-title":"Skin Therapy Letter"},{"key":"e_1_2_12_14_1","volume-title":"Draft Guidance on Fluocinolone Acetonide, Hydroquinone, and Tretinoin","author":"FDA","year":"2015"},{"issue":"1","key":"e_1_2_12_15_1","first-page":"67","article-title":"Efficacy and Safety of a New Triple\u2010Combination Agent for the Treatment of Facial Melasma","volume":"72","author":"Taylor S. C.","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690060057005"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2017.01.020"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555\u2010017\u20100194\u20101"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100749.1988.tb00140.x"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806\u20104841.201755325"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425\u2010018\u20100371\u20105"},{"issue":"5","key":"e_1_2_12_22_1","first-page":"592","article-title":"A Large 12\u2010Month Extension Study of an 8\u2010Week Trial to Evaluate the Safety and Efficacy of Triple Combination (TC) Cream in Melasma Patients Previously Treated With TC Cream or One of Its Dyads","volume":"4","author":"Torok H.","year":"2005","journal-title":"Journal of Drugs in Dermatology"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102133.2008.08717.x"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007\u20100963.2001.04556.x"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000154419.18653.2e"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20104632.2007.03351.x"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.70205","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jocd.70205","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.70205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:29:55Z","timestamp":1773718195000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.70205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/jocd.70205"],"URL":"https:\/\/doi.org\/10.1111\/jocd.70205","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"2024-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70205"}}